Autoimmunity, spontaneous tumourigenesis, and IL-15 insufficiency in mice with a targeted disruption of the tumour suppressor gene Fus1

• Published in: The Journal of pathology 2007-04, Vol.211 (5), p.591-601
• Main Authors: Ivanova, AV, Ivanov, SV, Pascal, V, Lumsden, JM, Ward, JM, Morris, N, Tessarolo, L, Anderson, SK, Lerman, MI
• Format: Article
• Language: English
• Subjects: Animals; autoimmunity; Autoimmunity - genetics; Autoimmunity - immunology; Fus1 knockout; Genes, Tumor Suppressor - physiology; Hemangioma - genetics; Hemangioma - immunology; Hemangiosarcoma - genetics; Hemangiosarcoma - immunology; IL-15; Immunity, Innate - immunology; Interleukin-15 - immunology; Killer Cells, Natural - immunology; Mice; Mitochondria - genetics; Neoplasm Proteins - genetics; Neoplasm Proteins - immunology; Neoplasms - genetics; Neoplasms - immunology; Phenotype; Protein Precursors - analysis; Protein Precursors - deficiency; Protein Precursors - genetics; RNA, Messenger - genetics; Tissue Distribution - genetics; Tumor Suppressor Proteins; tumour suppressor; Ubiquitins - analysis; Ubiquitins - deficiency; Ubiquitins - genetics; Vasculitis - genetics
• ISSN: 0022-3417; 1096-9896
• DOI: 10.1002/path.2146

The Fus1 gene resides in the critical 3p21.3 human chromosomal region deleted in lung and breast cancers. Recently, the tumour suppressor properties of Fus1 were confirmed experimentally by intra‐tumoural administration of Fus1 that suppressed experimental lung metastasis in mice. We generated Fus1‐deficient mice that were viable, fertile, and demonstrated a complex immunological phenotype. Animals with a disrupted Fus1 gene developed signs of autoimmune disease, such as vasculitis, glomerulonephritis, anaemia, circulating autoantibodies, and showed an increased frequency of spontaneous vascular tumours. Preliminary analysis of immune cell populations revealed a consistent defect in NK cell maturation in Fus1 null mice that correlated with changes in the expression of IL‐15. Injection of IL‐15 into Fus1 knockout mice completely rescued the NK cell maturation defect. Based on these results, we propose the hypothesis that Fus1 deficiency affects NK cell maturation through the reduction of IL‐15 production but does not directly alter their developmental capacity. Since acquired immunity was not affected in Fus1‐deficient animals, we suggest a relationship between the Fus1 protein and the regulation of innate immunity via IL‐15 production. The increased frequency of spontaneous cancers and the development of an autoimmune syndrome in Fus1 null mice imply that these mice could serve as a model for studying molecular mechanisms of anti‐tumour immunity and autoimmunity. Published in 2007 by John Wiley & Sons, Ltd.